Mutation in the HPGD gene encoding NAD+ dependent 15-hydroxyprostaglandin dehydrogenase underlies isolated congenital nail clubbing (ICNC)

Journal of Medical Genetics

Volumn 46, Issue 1, 2009, Pages 14-20

  Tariq, M ^a   Azeem, Z ^a   Ali, G ^a   Chishti, M S ^a   Ahmad, W ^a  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYPROSTAGLANDIN DEHYDROGENASE; DNA;

ARTICLE; CHROMOSOME 4Q; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; EXON; FAMILY; FEMALE; GENE IDENTIFICATION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC LINKAGE; HOMOZYGOSITY; HUMAN; ISOLATED CONGENITAL NAIL CLUBBING; MALE; MICROSATELLITE MARKER; MISSENSE MUTATION; NAIL DISEASE; NUCLEOTIDE SEQUENCE; PAKISTAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL;

BASE SEQUENCE; CHROMOSOMES, HUMAN, PAIR 4; CONSANGUINITY; DINOPROSTONE; FEMALE; GENES, RECESSIVE; GENOTYPE; HAPLOTYPES; HUMANS; HYDROXYPROSTAGLANDIN DEHYDROGENASES; LINKAGE (GENETICS); MALE; MOLECULAR SEQUENCE DATA; MUTATION; NAIL DISEASES; NAILS, MALFORMED; PEDIGREE; PHENOTYPE;

EID: 58549113186     PISSN: 00222593     EISSN: 14686244     Source Type: Journal    
DOI: 10.1136/jmg.2008.061234     Document Type: Article

References (35)

1. Myers KA, Farquhar DR. The rational clinical examination. Does this patient have clubbing? JAMA 2001;286:341-7.
2. Fenton AD. Nail disorders associated with general medical conditions. In: Samman's the nails in disease, 5th ed. Oxford: Butterworth-Heinemann Ltd, 1995:113-4.
3. Marrie TJ, Brown N. Clubbing of the digits. Am J Med 2007; 120:940-1.
4. Dawber R, de Berker D, Baran, B. Diseases of the nails and their management. Oxford: Blackwell Science, 2001.
5. Sambrook J, Russell DW. Preparation and analysis of eukaryotic genomic DNA. In: Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory Press, 2001,1:6.4-6.11.
6. Hassan MJ, Chishti MS, Jamal SM, Tariq M, Ahmad W. A syndromic form of autosomal recessive congenital microcephaly (Jawad syndrome) maps to chromosome 18p11.22-q11.2. Hum Genet 2008; 123:77-82.
7. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 1998;63:259-66.
8. Abecasis GR, Cherny SS, Cookson WO, Cardon LR. Merlin-rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002;30:97-101.
9. Weeks DE, Sobel E, O'Connell JR, Lange K. Computer programs for multilocus haplotyping of general pedigrees. Am J Hum Genet 1995;56:1506-7.
10. Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996;58:1323-37.
11. Cottingham RW Jr, Jonasson K, Frigge ML, Kong A. Faster sequential genetic linkage computations. Am J Hum Genet 1993; 53:252-63.
12. Gudbjartsson DF, Thorvaldsson T, Kong A, Gunnarsson G, Ingolfsdottir A. Allegro version 2. Nat Genet 2005; 37:1015-6.
13. Kong X, Murphy K, Raj T, He C, White PS, Matise TC. A combined linkage-physical map of the human genome [erratum in: Am J Hum Genet 2005;76:373]. Am J Hum Genet 2004;75:1143-8.
14. Rozen S, Skaletsky HJ. Primer3 on the WWW for general users and for biologist programmers. In: Krawetz S, Misener S, eds. Bioinformatics methods and protocols: methods in molecular biology. New Jersey: Humana, 2000:365-86.
15. Tariq M, Wasif N, Ayub M, Ahmad W. A novel 4-bp insertion mutation in EDA1 gene in a Pakistani family with X-linked hypohidrotic ectodermal dysplasia. Eur J Dermatol 2007;17:209-12.
16. Anggård E, Larsson C, Samuelsson B. The distribution of 15-hydroxy prostaglandin dehydrogenase and prostaglandin-delta 13-reductase in tissues of the swine. Acta Physiol Scand 1971; 81:396-404.
17. Tai HH. Enzymatic synthesis of (15s)-[15-3h]prostaglandins and their use in the development of a simple and sensitive assay for 15-hydroxylprostaglandin dehydrogenase. Biochemistry 1976; 15:4586-92.
18. Pichaud F, Frendo JL, Delage-Mourroux R, de Vernejoul MC, Moukhtar MS, Jullienne A. Sequence of a novel mRNA coding for a C-terminal-truncated form of human NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. Gene 1995; 162:319-22.
19. Basu S, Stjernschantz J. Delta13-reductase dependent metabolism of prostaglandins in the mammalian brain and eye. Prostaglandins Leukot Essent Fatty Acids 1997;57:305-10.
20. Uppal S, Diggle CP, Carr IM, Fishwick CW, Ahmed M, Ibrahim GH, Helliwell PS, Latos-Bieleńska A, Phillips SE, Markham AF, Bennett CP, Bonthron DT. Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy. Nat Genet 2008; 40:789-93.
21. Jajic Z, Jajic I, Nemcic T. Primary hypertrophic osteoarthropathy: clinical, radiologic, and scintigraphic characteristics. Arch Med Res 2001;32:136-42.
22. Tai HH, Ensor CM, Tong M, Zhou H, Yan F. Prostaglandin catabolizing enzymes. Prostaglandins Other Lipid Mediat 2002; 68-69:483-93.
23. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 1999; 79:1193-226.
24. Nomura T, Lu R, Pucci ML, Schuster VL. The two-step model of prostaglandin signal termination: in vitro reconstitution with the prostaglandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol 2004;65:973-8.
25. Anggård E. The biological activities of three metabolites of prostaglandin E 1. Acta Physiol Scand 1966;66:509-10.
26. Ensor CM, Tai HH. 15-Hydroxyprostaglandin dehydrogenase. J Lipid Mediat Cell Signal 1995;12:313-9.
27. Okita RT, Olkita JR. Prostaglandin-metabolizing enzymes during pregnancy: characterization of NAD(+)-dependent prostaglandin dehydrogenase, carbonyl reductase, and cytochrome P450-dependent prostaglandin omega-hydroxylase. Crit Rev Biochem Mol Biol 1996; 31:101-26.
28. Höhl W, Stahl B, Mundkowski R, Hofmann U, Meese CO, Kuhlmann U, Schlegel W. Mass determination of 15-hydroxyprostaglandin dehydrogenase from human placenta and kinetic studies with (5Z, 8E, 10E, 12S)-12-hydroxy-5,8,10-heptadecatrienoic acid as substrate. Eur J Biochem 1993;214:67-73.
29. Chavan AJ, Ensor CM, Wu P, Haley BE, Tai HH. Photoaffinity labeling of human placental NAD(+)-linked 15-hydroxyprostaglandin dehydrogenase with [alpha-32P]2N3NAD+. Identification of a peptide in the adenine ring binding domain. J Biol Chem 1993; 268:16437-42.
30. Krook M, Ghosh D, Duax W, Jörnvall H. Three-dimensional model of NAD(+)-dependent 15-hydroxylprostaglandin dehydrogenase and relationships to the NADP(+)-dependent enzyme (carbonyl reductase). FEBS Lett 1993;322:139-42.
31. Ensor CM, Tai HH. Bacterial expression and site-directed mutagenesis of two critical residues (tyrosine-151 and lysine-155) of human placental NAD(+)-dependent 15-hydroxyprostaglandin dehydrogenase. Biochim Biophys Acta 1994;1208:151-6.
32. Ensor CM, Tai HH. Site-directed mutagenesis of the conserved serine 138 of human placental NAD+-dependent 15-hydroxyprostaglandin dehydrogenase to an alanine results in an inactive enzyme. Biochem Biophys Res Commun 1996;220:330-3.
33. Jörnvall H, Persson B, Krook M, Atrian S, Gonzàlez-Duarte R, Jeffery J, Ghosh D. Short-chain dehydrogenases/ reductases (SDR). Biochemistry 1995;34:6003-13.
34. Zhou H, Yan F, Tai HH. C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates. Eur J Biochem 2001; 268:3368-74.
35. Tai HH, Cho H, Tong M, Ding Y. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Curr Pharm Des 2006;12:955-62.